Research suggests that routine pathology slides may be used to improve breast cancer risk assessment, with some studies indicating that ai tests can predict breast cancer recurrence and chemotherapy benefit. These tests, which can analyze standard pathology slides, may be able to provide results in a matter of hours. The use of ai models and computational pathology in breast cancer is being explored for its potential to optimize molecular prediction and improve treatment outcomes.